Diastolic clamp for bioimpedance measuring device

• US 4,870,578 A
• Filed: 08/17/1988
• Issued: 09/26/1989
• Est. Priority Date: 08/19/1987
• Status: Expired due to Fees

• Current Assignee: Cardiodynamics International Corporation (Fujifilm Holdings Corporation)
• Original Assignee: Cardiodynamics International Corporation (Fujifilm Holdings Corporation)
• Inventors: Vysin, Vlastimil P., Sramek, Bohumir
• Primary Examiner(s): NOT, DEFINED
• Application Number:
  US07/232,481
• Time in Patent Office: 405 Days
• Field of Search: 364/413.07, 364/413.05, 128/671, 128/693, 128/709, 128/723, 128/708, 128/734
• US Class Current: 600/509
• CPC Class Codes: A61B 5/0295 using plethysmography, i.e. measuring the variations in the volume of a body part as modified by the circulation of blood therethrough, e.g. impedance plethysmography
• CPC Class Codes: A61B 5/0535 Impedance plethysmography for measuring blood flow A61B5/0295
• CPC Class Codes: A61B 5/0809 by impedance pneumography
• CPC Class Codes: A61B 5/352 Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
• CPC Class Codes: A61B 5/7239 using differentiation including higher order derivatives

Abstract

An electrical bioimpedance measuring device is used to measure changes in the electrical resistance of a segment of the thorax of a human body caused by changes in the blood perfusion in that segment resulting from the pumping action of the heart. The electrical resistance of also changes as a result of respiration, and the respiratory-induced changes are typically much larger than the cardiac-induced changes and cause large changes in the voltages in the measuring equipment. In order to suppress the large voltage changes, a clamping circuit is included that is synchronized with the electrical activity of the heart. The clamping circuit is timed to clamp the voltages in the measuring equipment to a baseline reference voltage in the time preceding the beginning of mechanical systole. The voltage clamping is released during the mechanical systole of the heart so that the changes in the voltages (i.e., the bioimpedance changes) caused by the pumping action of the heart during mechanical systole can be measured.

Claims

1. A non-invasive apparatus for measuring cardiac output of a patient, comprising:

a bioimpedance measuring device that produces an electrical bioimpedance signal indicative of the thoracic impedance as a function of time;

a differentiating circuit that receives a signal responsive to said electrical bioimpedance signal, and that differentiates said signal responsive to said electrical bioimpedance signal to generate a differentiated electrical signal indicative of the rate of change of thoracic impedance as a function of time; and

a clamping circuit that periodically clamps said differentiated electrical signal to a fixed predetermined reference voltage so that said differentiated electrical signal is active only for a predetermined time duration following the beginning of each cardiac cycle.

2. The apparatus as defined in claim 1, wherein said bioimpedance measuring device comprises:

a current source having a high frequency constant amplitude electrical current output;

a pair of injector electrodes that inject the current output into a fist portion of a patient'"'"'s body;

a pair of sensor electrodes that sense a voltage across a second portion of the patient'"'"'s body caused by current flow in said first portion of the patient'"'"'s body; and

an amplifier connected to said pair of sensor electrodes that receives said voltage and generates said electrical signal indicative of the thoracic impedance as a function of time.

3. The apparatus as defined in claim 1, wherein said clamping circuit comprises an electrically controlled switch, said switch being timed to be closed except during said predetermined time following the beginning of each cardiac cycle.

4. The apparatus as defined in claim 3, further including a timing circuit to control said switch, said timing circuit providing an output signal that controls the closing of said switch, said timing circuit responsive to the ECG output signals from the heart of the patient so that the operation of said switch is synchronized with the ECG output signals from the heart of the patient.

5. The apparatus as defined in claim 3, wherein said electrically controlled switch is located at the input of said differentiating circuit so that said electrically controlled switch clamps said signal responsive to said electrical bioimpedance signal.

6. The apparatus as defined in claim 3, wherein said electrically controlled switch is located at the output of said differentiating circuit.

7. A method of measuring the cardiac output of the heart of a patient comprising the steps of:

applying a high frequency constant current to a first portion of the patient'"'"'s body;

sensing a voltage developed across a second portion of the patient'"'"'s body caused by the flow of said high frequency constant current through said first portion;

amplifying said sensed voltage;

differentiating said sensed voltage to provide a differentiated output signal; and

clamping said differentiated output signal to a fixed predetermined reference voltage for a predetermined amount of time during each cardiac cycle so that said differentiated output signal has a fixed magnitude during a selected time period prior to the mechanical systole of the patient'"'"'s heart and has a variable magnitude corresponding to the rate of change of said sensed voltage during the mechanical systole of the heart.